<DOC>
	<DOCNO>NCT01312350</DOCNO>
	<brief_summary>The investigator examine whether 2-cycles DFP chemotherapy definitive concurrent chemoradiation therapy ( CCRT ) improve progression-free survival locally advance ( Stage III &amp; IVM0 ) hypopharyngeal base tongue carcinoma compare definitive CCRT alone .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Locally Advanced Squamous Cell Cancer Head Neck ( SCCHN )</brief_title>
	<detailed_description />
	<mesh_term>Hypopharyngeal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically/cytologically proven stage III/IVM0 hypopharyngeal base tongue cancer One evaluable measurable lesion No prior chemotherapy , radiation , surgery ECOG 02 Distant metastasis Other malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>definitive chemoradiation therapy</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>base tongue</keyword>
	<keyword>Locally advanced</keyword>
</DOC>